Nabil Uddin
Corporate Officer/Principal chez CONCERT PHARMACEUTICALS, INC.
Profil
Nabil Uddin is currently working as the Vice President-Corporate Development at Concert Pharmaceuticals, Inc. He holds a doctorate degree from the Massachusetts College of Pharmacy & Health Science and an undergraduate degree from McMaster University.
Postes actifs de Nabil Uddin
Sociétés | Poste | Début |
---|---|---|
CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Nabil Uddin
McMaster University | Undergraduate Degree |
Massachusetts College of Pharmacy & Health Science | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |